Example: quiz answers

WHO International Biological Reference Preparations

Held and Distributed by the WHO International Laboratories for Biological StandardsWHO International Biological Reference PreparationsPREPARATIONSTANDARDMATERIALH ELD AT CODE WHO/BSDOCUMENTBLOOD PRODUCTS AND RELATED SUBSTANCES: Blood Anti-A blood grouping minimum potency reagent, Lyophilized, A 1 in 8 dilution defines the recommended minimum potency specification for anti-A blood grouping IgM (murine)03 International Standard, 2005 blood grouping minimum potency reagent, Lyophilized, A 1 in 4 dilution defines the recommended minimum potency specification for anti-B blood grouping IgM (murine)

PREPARATION STANDARD MATERIAL HELD AT CODE WHO/BS DOCUMENT BLOOD PRODUCTS AND RELATED SUBSTANCES: Blood safety http://www.who.int/bloodproducts/cs/en/031987.pdf

Tags:

  International, Product, Biological, Reference, Safety, Preparation, Who international biological reference preparations

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of WHO International Biological Reference Preparations

1 Held and Distributed by the WHO International Laboratories for Biological StandardsWHO International Biological Reference PreparationsPREPARATIONSTANDARDMATERIALH ELD AT CODE WHO/BSDOCUMENTBLOOD PRODUCTS AND RELATED SUBSTANCES: Blood Anti-A blood grouping minimum potency reagent, Lyophilized, A 1 in 8 dilution defines the recommended minimum potency specification for anti-A blood grouping IgM (murine)03 International Standard, 2005 blood grouping minimum potency reagent, Lyophilized, A 1 in 4 dilution defines the recommended minimum potency specification for anti-B blood grouping IgM (murine)

2 03 International Standard, 2005 NIBSCAnti-c incomplete blood typing serum, Lyophilized, 64 IU/ampouleHuman International Standard, 1976 NIBSCAnti-D (anti-Rho) minimum potency reagent, complete, Lyophilized, A 1 in 3 dilution defines the recommended minimum potency specification for low protein anti-D blood reagents; a 1 in 8 dilution defines the recommended minimum potency specification for high protein anti-D IgM (human)99 Rev. 11st International Standard, 2004 B virus e antigen (anti-HBe), Lyophilized, 120 IU/mLHuman plasma129095/12 International Standard, 2013 B virus core antibodies (anti-HBc), Lyophilized, 50 IU/vialHuman plasma95 International Standard, 2008 NIBSCAnti-HIV antibodies (HIV-1 subtypes A, B, C, CRF01,_AE, group O and HIV-2), Lyophilized, No unitage plasma02 International Reference Panel, 2006 cruzi I antibody (TcI), Lyophilized, 1 IU / mlHuman plasma09 International Standard, 2011 cruzi II antibody (TcII)

3 , Lyophilized, 1 IU / mlHuman plasma09 International Standard, 2011 Barr virus DNA, Lyophilized, 5,000,000 IU/mlB95-8 strain formulated in universal buffer09 International Standard, 2011 A virus RNA, Lyophilized, 54,000 IU/mLHuman plasma00 International Standard, 2013 B Surface Antigen, Lyophilized., 50 IU / mlOther substances12 International Standard, 2014 B virus e antigen (HBeAg), Lyophilized, 100 IU/mLHuman serum129097/12 International Standard, 2013 B virus DNA, Lyophilized, 850,000 IU/vial (~ log10 IU/ml)

4 Human plasma10 International Standard, 2011 B virus DNA, Genotypes A, B, C, D, E, F, G, Lyophilized, No unitage assignedHuman plasma5086/08 International Reference Panel, 2009 B virus surface antigen, fifteen panel members representing genotypes A-F and H, Lyophilized, No unitage assignedHuman plasma6100/09 International Reference Panel, 2011 Hepatitis B virus surface antigen, subtype adw2, genotype A, Lyophilized, 33 plasma00 International Standard, 2003 NIBSCPage 1 of 2 This Catalogue is available at the following WHO Web site address: February 2015 PREPARATIONSTANDARDMATERIALHELD AT CODE WHO/BSDOCUMENTBLOOD PRODUCTS AND RELATED SUBSTANCES: Blood Hepatitis B virus surface antigen, subtype adw2, genotype A, Lyophilized, Dilutional panel (IU/vial: ; ; ; ).

5 Human plasma03 International Reference Panel, 2003 C Virus core antigen, Lyophilized., 3,200 IU / mlOther substancesPEI code 129096 International Standard, 2014 C virus RNA, Lyophilized, 260,000 IU/ml (~ log10 IU/ml).Human plasma06 International Standard, 2011 /10665/96341/1 /10665/96341/1 /10665/96341/1 /10665/96341/1 D virus RNA, Lyophilized, 575,000 IU/mLHuman plasma7657/12 International Standard, 2013 E virus RNA, Lyophilized, 250,000 IU/mlHuman plasma10/6329 International Standard, 2011 Circulating Recombinant Forms (CRFs)

6 RNA, ten panel members consisting of CRFs and other variants, Lyophilized, No unitage assignedHuman plasma13 International Reference Panel, 2013 NIBSCHIV-1 p24 antigen, Lyophilized, 1,000 IU/ampoulePeptide in human serum90 International Reference Reagent, 1992 RNA, Lyophilized, 185,000 IU/ml ( log10 IU/ml)HIV-1 genotype B isolate diluted in human plasma10 International Standard, 2011 RNA subtype Reference panel (A, B, C, D, AE, F, G, AG-GH, groups N and O), Lyophilized, No unitage assignedHuman plasmaCandidate HIV-1 NAT International Reference Panel, 2012 NIBSCHIV-2 RNA, Lyophilized, 1000 IU/vialHuman plasma08 International Standard, 2009 cytomegalovirus DNA, Lyophilized, 5,000,000 strain09 International Standard, 2010 B19 DNA, Lyophilized, 1,410,000 IU/mLParvovirus B19 positive donation diluted in plasma12 International Standard, 2013 B19 DNA, Genotypes 1,2,3a, negative control, Liquid frozen, No unitage assignedHuman plasma09 International Reference Panel.

7 2009 falciparum DNA, Lyophilized, 500,000,000 blood04 International Standard, 2006 , RBC4, RBC5, RBC12 blood group genotyping alleles, Lyophilized, No unitage assignedGenomic DNA10/232, 10/234, 10/236, 10 Reference Panel, 2011 /10665/137478/1 /10665/137478/1 /10665/137478/1 /10665/137478/1 gondii NAT assay, Lyophilized., 1,000,000 IU / mlOther substances10 International Standard, 2014 NIBSCPage 2 of 2 This Catalogue is available at the following WHO Web site address: February 2015


Related search queries